214450 — PharmaResearch Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapHigh Flyer

Market Cap
KR₩7tn
Enterprise Value
KR₩7tn
Revenue
KR₩350bn

Annual balance sheet for PharmaResearch Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	79,267	156,798	184,343	160,298	437,351
Net Total Accounts Receivable
Net Total Receivables	26,351	30,510	36,415	36,330	56,624
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	127,404	206,792	247,345	256,465	554,542
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	94,046	109,481	117,960	123,061	147,313
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	319,831	427,647	478,055	535,281	855,701
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	35,849	48,005	54,253	65,899	82,818
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	74,409	122,205	134,552	102,178	316,299
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	245,423	305,442	343,503	433,104	539,402
Total Liabilities & Shareholders' Equity	319,831	427,647	478,055	535,281	855,701
Total Common Shares Outstanding
Total Preferred Shares Outstanding